The Anthrax Treatment Market will register a CAGR of more than 8% by 2023

Wednesday, December 12, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Dec. 11, 2018 /PRNewswire/ -- About this marketThe increase in funding for research on anthrax vaccine across

the globe is likely to boost the market growth. The new funding will allow additional vaccine characterization and inspection of mucosal immune response. Technavio's analysts have predicted that the anthrax treatment market will register a CAGR of more
than 8% by 2023.Download the full report: https://www.reportbuyer.com/product/5647234 Market OverviewDevelopment of novel therapies for treatment of anthraxThere has been an increase in the development of novel therapies for anthrax due to the increasing threat of exposure to Bacillus anthracis among civilian populations and military forces.Challenges associated with early diagnosisThere are challenges associated with early diagnosis of anthrax. Several anthrax cases have gone undetected. Such cases pose a threat to the anthrax treatment market.For the detailed list of factors that will drive and challenge the growth of the anthrax treatment market during the 2019-2023, view our report.Competitive LandscapeThe market appears to be fragmented and with the presence of several companies including Bayer, and Emergent BioSolutions the competitive environment is quite intense. Factors such as the increase in development of new therapies and increase in research funding, will provide considerable growth opportunities to anthrax treatment manufactures. Bayer, Elusys Therapeutics, and Emergent BioSolutions are some of the major companies covered in this report.'With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities. Several companies are developing vaccines and therapeutics for bioterrorism-associated anthrax including Elusys Therapeutics.'Download the full report: https://www.reportbuyer.com/product/5647234 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-anthrax-treatment-market-will-register-a-cagr-of-more-than-8-by-2023-300763672.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store